Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
37.27 USD | -0.11% | +15.28% | -18.54% |
Financials (USD)
Sales 2024 * | 10M | Sales 2025 * | 6.25M | Capitalization | 1.09B |
---|---|---|---|---|---|
Net income 2024 * | -22M | Net income 2025 * | -25M | EV / Sales 2024 * | 102 x |
Net cash position 2024 * | 63.14M | Net cash position 2025 * | 40.52M | EV / Sales 2025 * | 167 x |
P/E ratio 2024 * |
-48.7
x | P/E ratio 2025 * |
-45.3
x | Employees | 20 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 19.31% |
Latest transcript on Belite Bio, Inc
1 day | -0.11% | ||
1 week | +15.28% | ||
Current month | -2.87% | ||
1 month | -15.20% | ||
3 months | -18.93% | ||
6 months | -1.53% | ||
Current year | -18.54% |
Managers | Title | Age | Since |
---|---|---|---|
Yue Hsin Lin
CEO | Chief Executive Officer | 46 | 18-03-26 |
Hao Yuan Chuang
DFI | Director of Finance/CFO | 40 | 20-10-31 |
Nathan L. Mata
CTO | Chief Tech/Sci/R&D Officer | 58 | 21-10-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 72 | 22-03-31 | |
Yi Ta Lue
BRD | Director/Board Member | 47 | 22-03-31 |
John Longo
BRD | Director/Board Member | 55 | 22-03-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.00% | 117 M€ | +0.68% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-24 | 37.27 | +0.73% | 32,733 |
24-04-23 | 37 | +7.31% | 38,820 |
24-04-22 | 34.48 | +3.14% | 9,447 |
24-04-19 | 33.43 | -3.38% | 20,859 |
24-04-18 | 34.6 | +7.02% | 24,316 |
Delayed Quote Nasdaq, April 24, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-18.54% | 1.09B | |
+4.09% | 43.84B | |
+46.79% | 41.25B | |
+9.45% | 41.68B | |
-10.92% | 27.04B | |
+9.32% | 25.53B | |
-24.87% | 18.18B | |
+29.70% | 12.29B | |
+1.28% | 12.29B | |
+7.78% | 11.15B |
- Stock Market
- Equities
- BLTE Stock